PULMONX: BREATH OF FRESH AIR FOR LUNG DISEASE PATI
Post# of 1
$LUNG
Excited to share an article about Pulmonx Corp (NASDAQ: LUNG), a global leader in minimally invasive treatments for lung disease. The Company has created a highly effective solution for patients with severe emphysema.
Pulmonx operates in an industry where the target market has highly unmet medical needs - thus, by providing a valuable and well-received solution, it may succeed in scaling new heights.
Read on to know more:
https://www.aviseanalytics.com/pulmonx-breath...-patients/